{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:31:00Z","timestamp":1787887860276,"version":"build-2784847793"},"reference-count":39,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"crossref","award":["LMS25H200003"],"award-info":[{"award-number":["LMS25H200003"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFD1800400"],"award-info":[{"award-number":["2022YFD1800400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2026,1,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Carbapenem-resistant\n                      <jats:italic toggle=\"yes\">Pseudomonas aeruginosa<\/jats:italic>\n                      (CRPA) presents a serious clinical challenge due to limited treatment options. Ceftazidime\u2013avibactam (CZA) is a critical last-resort agent against multidrug-resistant Gram-negative pathogens; however, resistance is emerging, particularly mediated by\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>KPC<\/jats:sub>\n                      variants. In this study, we investigated the prevalence and mechanisms of CZA resistance among CRPA isolates collected from two tertiary hospitals in Hangzhou between 2021 and 2022. A total of 273 non-duplicate CRPA isolates were screened, among which 13.9% (38\/273) exhibited CZA resistance (MIC \u2265 16 \u00b5g\/mL). Whole-genome sequencing revealed that resistant strains were highly resistant to carbapenems, cephalosporins, and aztreonam but retained partial susceptibility to aminoglycosides and polymyxins. ST463 was the predominant sequence type (76.3%), strongly associated with\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>KPC-2<\/jats:sub>\n                      carriage and virulence genes, such as\n                      <jats:italic toggle=\"yes\">exoU<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">pldA<\/jats:italic>\n                      . Notably, three\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>KPC<\/jats:sub>\n                      variants\u2014KPC-14, KPC-33, and KPC-86\u2014were identified, all conferring high-level resistance to CZA (MIC &gt; 32 \u00b5g\/mL). KPC-86 was discovered for the first time in\n                      <jats:italic toggle=\"yes\">P. aeruginosa<\/jats:italic>\n                      , embedded in an IS\n                      <jats:italic toggle=\"yes\">26<\/jats:italic>\n                      -flanked transposon, suggesting potential for horizontal transfer. Sequential recovery of KPC-86 and KPC-33 from the same patient supports\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      evolution under antibiotic pressure. These findings highlight the evolving threat of CZA resistance in CRPA, driven by\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>KPC<\/jats:sub>\n                      diversification within high-risk clones. Continued genomic surveillance and antimicrobial stewardship are urgently needed to preserve the efficacy of CZA.\n                    <\/jats:p>\n                    <jats:sec>\n                      <jats:title>IMPORTANCE<\/jats:title>\n                      <jats:p>\n                        Ceftazidime\u2013avibactam (CZA) is one of the few remaining options to treat serious infections caused by drug-resistant\n                        <jats:italic toggle=\"yes\">Pseudomonas aeruginosa<\/jats:italic>\n                        . However, its effectiveness is now being threatened by emerging genetic changes that reduce susceptibility. In this study, we investigated CZA-resistant strains and uncovered three variants of the resistance gene\n                        <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                        <jats:sub>KPC<\/jats:sub>\n                        , including one\u2014KPC-86\u2014never before seen in\n                        <jats:italic toggle=\"yes\">P. aeruginosa<\/jats:italic>\n                        . This variant was located on a mobile genetic element, raising concerns about its potential to spread between bacteria. We also documented the evolution of resistance within a single patient, showing how treatment pressure can drive genetic change. By combining clinical, microbiological, and genomic data, our findings highlight an urgent need for ongoing surveillance and careful antibiotic use to preserve the usefulness of last-resort drugs like CZA. This work informs both clinicians and public health experts on emerging resistance threats.\n                      <\/jats:p>\n                    <\/jats:sec>\n                  <\/jats:sec>","DOI":"10.1128\/spectrum.02187-25","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T15:29:27Z","timestamp":1765207767000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":2,"title":["Novel KPC-2 variants and epidemic ST463 clones underlie ceftazidime\/avibactam resistance in carbapenem-resistant\n                    <i>Pseudomonas aeruginosa<\/i>"],"prefix":"10.1128","volume":"14","author":[{"given":"Yanyan","family":"Hu","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/059cjpv64","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Clinical Laboratory, Second Affiliated Hospital of Zhejiang University, School of Medicine","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8472-6559","authenticated-orcid":true,"given":"Qiaoling","family":"Sun","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05m1p5x56","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyi","family":"Shen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/059cjpv64","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Clinical Laboratory, Second Affiliated Hospital of Zhejiang University, School of Medicine","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Du","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/059cjpv64","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Clinical Laboratory, Second Affiliated Hospital of Zhejiang University, School of Medicine","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng","family":"Kaiqi","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/059cjpv64","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Clinical Laboratory, Second Affiliated Hospital of Zhejiang University, School of Medicine","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2174-7985","authenticated-orcid":true,"given":"Rong","family":"Zhang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/059cjpv64","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Clinical Laboratory, Second Affiliated Hospital of Zhejiang University, School of Medicine","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01635-6"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz243"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/gbe\/evx243"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz830"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2016.22"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae403"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01714-21"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01175-20"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01869-21"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.10.013"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00154-21"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2024.127893"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01539-07"},{"key":"e_1_3_5_15_2","volume-title":"CLSI document M100-S34","author":"Wayne P","year":"2024","unstructured":"Wayne P. 2024. Performance standards for antimicrobial susceptibility testing; 33rd informational supplement. In CLSI document M100-S34. Clinical and Laboratory Standards Institute."},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1089\/cmb.2012.0021"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.06094-11"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00349-16"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa345"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1239"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0072-8"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112963"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0524-x"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae268"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku316"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv004"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1098944"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.5.1633-1641.2006"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0266742"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw188"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2017.09.010"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02578"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.01344-21"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02097-16"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13100-025-00351-2"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03340-21"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2025.03.004"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47303-4"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2025.107521"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00787-21"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.02187-25","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.02187-25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T14:07:12Z","timestamp":1767708432000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.02187-25"}},"subtitle":[],"editor":[{"given":"Krisztina M.","family":"Papp-Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,6]]}},"alternative-id":["10.1128\/spectrum.02187-25"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.02187-25","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"2025-08-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e02187-25"}}